P.A.W. CAPITAL CORP - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 135 filers reported holding CONSTELLATION PHARMCETICLS I in Q2 2020. The put-call ratio across all filers is 0.02 and the average weighting 1.3%.

Quarter-by-quarter ownership
P.A.W. CAPITAL CORP ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q4 2020$1,440,000
-11.2%
50,000
-37.5%
1.27%
-28.0%
Q3 2020$1,621,000
-17.0%
80,000
+23.1%
1.76%
-20.1%
Q2 2020$1,953,000
-40.8%
65,000
-38.1%
2.21%
-50.3%
Q1 2020$3,300,000
-36.3%
105,000
-4.5%
4.44%
-19.6%
Q4 2019$5,182,000
+401.2%
110,000
-31.2%
5.52%
+328.3%
Q3 2019$1,034,000
-29.9%
160,000
+33.3%
1.29%
-19.1%
Q2 2019$1,474,000120,0001.59%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q2 2020
NameSharesValueWeighting ↓
Ponoi II Management, LLC 1,574,229$45,338,00033.03%
Ponoi Management, LLC 1,880,623$54,162,00030.99%
VR Adviser, LLC 4,016,873$115,686,00017.01%
Column Group LLC 2,626,631$75,647,0006.86%
COMMODORE CAPITAL LP 423,708$12,203,0006.64%
GREAT POINT PARTNERS LLC 1,024,800$29,514,0004.79%
Venrock Management V, LLC 1,557,276$44,850,0004.23%
Ghost Tree Capital, LLC 625,000$18,000,0004.01%
Euclidean Capital LLC 554,325$15,965,0003.38%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 737,406$21,237,0003.07%
View complete list of CONSTELLATION PHARMCETICLS I shareholders